Rubicon Research
RUBICON · NSEValuation
Blended fair value using DCF and peer comparison methods.
See if Rubicon Research is undervalued
Unlock intrinsic value for 4,800+ Indian stocks — free.
Sign in or create free accountThe intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.
Peer comparison
How this company stacks up against sector peers on valuation and quality metrics.
Healthcare · 8 peers · sector medians shown
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
Rubicon Research RUBICON · you | ₹27,676 Cr | 117.4× | — | — | — | 0.2% | — |
| Sector median | — | 45.1× | 6.7× | 27.2× | 12.6% | 7.3% | 10.2% |
| Manipal Health Enterprises Limited MANIPALHOS | ₹1.0 L Cr | 106.8× | 11.3× | 42.9× | 10.6% | 8.6% | 28.8% |
| Dr. Agarwal's Health Care Limited AGARWALEYE | ₹16,045 Cr | 349.0× | — | — | — | 0.0% | — |
| Alembic Pharmaceuticals Limited APLLTD | ₹15,334 Cr | 24.2× | 2.9× | 15.6× | 11.9% | 9.2% | 9.1% |
| Park Medi World Limited PARKHOSPS | ₹12,549 Cr | 40.9× | 6.0× | 27.2× | 12.8% | 15.4% | 10.2% |
| Akums Drugs and Pharmaceuticals Limited AKUMS | ₹12,161 Cr | 45.1× | 3.5× | 20.9× | 7.7% | 5.9% | 6.0% |
| Thyrocare Technologies Limited THYROCARE | ₹9,929 Cr | 60.9× | 20.7× | — | 34.0% | 0.2% | — |
| Jupiter Life Line Hospitals Limited JLHL | ₹9,880 Cr | 53.4× | 6.7× | 29.1× | 12.6% | 12.9% | 18.9% |
| Procter & Gamble Health Limited PGHL | ₹9,850 Cr | 27.6× | 16.1× | — | 58.5% | 0.3% | — |
Rubicon trades at a premium to sector peers on P/E (112.8× vs median 45.1×). The market is pricing in higher growth — worth verifying whether recent revenue trends support that expectation.
Business quality
Valuation
Returns
Growth
Efficiency
Liquidity & Solvency
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.